Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-037172
Filing Date
2025-03-11
Accepted
2025-03-11 16:23:59
Documents
80
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K vrca-20241231.htm   iXBRL 10-K 2930468
2 EX-19.1 vrca-ex19_1.htm EX-19.1 79715
3 EX-23.1 vrca-ex23_1.htm EX-23.1 4617
4 EX-31.1 vrca-ex31_1.htm EX-31.1 12747
5 EX-31.2 vrca-ex31_2.htm EX-31.2 13250
6 EX-32.1 vrca-ex32_1.htm EX-32.1 11438
7 GRAPHIC img255402386_0.jpg GRAPHIC 186841
  Complete submission text file 0000950170-25-037172.txt   12350499

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT vrca-20241231.xsd EX-101.SCH 1715916
83 EXTRACTED XBRL INSTANCE DOCUMENT vrca-20241231_htm.xml XML 2015271
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

EIN.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38529 | Film No.: 25727942
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)